Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis.
about
P16INK4a overexpression and survival in osteosarcoma patients: a meta analysishMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcomaNY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcomaMicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cellsGene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapyNew targets for the immunotherapy of colon cancer-does reactive disease hold the answer?Epigenetic alterations in osteosarcoma: promising targets.Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?Adoptive immunotherapy against sarcomas.MAGE-A3: an immunogenic target used in clinical practice.Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcomaImpact of Preferentially Expressed Antigen of Melanoma on the Prognosis of Hepatocellular Carcinoma.MAGEA4 expression in bone and soft tissue tumors: its utility as a target for immunotherapy and diagnostic marker combined with NY-ESO-1.
P2860
Q27009461-1AC963B0-D2A6-44CA-9376-1FD0D426E313Q33913833-79161F5C-D8C7-4B17-B671-9DB7F3E71D9EQ34786566-DFC12F59-2576-4926-87AC-1B713832B308Q35992165-59185BAE-F356-4D87-AAD1-10A6BC47E541Q36594516-E383CDA0-865A-46AC-BBA3-BC84C65692A2Q36714088-028308D0-B2AF-41B6-81F9-92D54E5D96C9Q36782428-69A199FC-0F48-45AC-919E-DD53AE4A363FQ37185223-12BA2835-8AD0-4217-A73D-9DC36F3E037EQ38089480-024CCDD6-CED0-438D-9F7E-996A861709ECQ38185555-D7F87DEE-9181-44C5-9A16-8835017032C8Q38209599-8A50C04F-47A9-41B0-B610-95CDC506606DQ38291193-963FFC80-20C4-4B56-9AD7-B041752C761EQ38534721-D4DDDF9C-68DB-4160-9FE7-C46691DBAC68Q39246205-512842E1-20F1-4614-86B3-3695ED2191A5Q42211126-87DDB911-3550-49FB-8E1B-C38392CA36D2Q54489272-000A23E8-043E-4D03-A723-F09ADAD518CA
P2860
Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Cancer-testis antigens express ...... with a poor patient prognosis.
@en
Cancer-testis antigens express ...... with a poor patient prognosis.
@nl
type
label
Cancer-testis antigens express ...... with a poor patient prognosis.
@en
Cancer-testis antigens express ...... with a poor patient prognosis.
@nl
prefLabel
Cancer-testis antigens express ...... with a poor patient prognosis.
@en
Cancer-testis antigens express ...... with a poor patient prognosis.
@nl
P2093
P2860
P356
P1433
P1476
Cancer-testis antigens express ...... with a poor patient prognosis.
@en
P2093
Changye Zou
Gang Huang
Jingnan Shen
Junqiang Yin
Qinglian Tang
Xianbiao Xie
Zheng Yang
P2860
P304
P356
10.1002/CNCR.26486
P407
P577
2011-08-26T00:00:00Z